{
    "organizations": [],
    "uuid": "fd733da428cd81e0e6dd9f9199c11a5d0f972fcf",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-molecular-partners-fy-net-loss-of/brief-molecular-partners-fy-net-loss-of-chf-25-4-million-idUSFWN1PY0DY",
    "ord_in_thread": 0,
    "title": "BRIEF-Molecular Partners FY Net Loss Of CHF 25.4 Million",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 8 (Reuters) - MOLECULAR PARTNERS AG:\n* 2017 FINANCIAL PERFORMANCE IN-LINE WITH EXPECTATIONS AND GUIDANCE\n* MOLECULAR PARTNERS-ONGOING STRONG FINANCIAL POSITION WITH CHF 141.1 MILLION IN CASH AND SHORT-TERM TIME DEPOSITS AS OF DEC 31, 2017\n* NET CASH USED IN OPERATING ACTIVITIES OF CHF 40.0 MILLION IN 2017\n* OPERATING LOSS OF CHF 25.8 MILLION AND NET LOSS OF CHF 25.4 MILLION IN 2017\n* ABICIPAR: ALLERGAN ON TRACK TO PRESENT ONE-YEAR PHASE 3 EFFICACY DATA IN H2 2018\n* JÖRN ALDAG, CURRENT CHAIRMAN, INDICATED WISH NOT TO STAND FOR RE-ELECTION AT THE 2018 AGM\n* FOR THE FULL YEAR 2018, AT CONSTANT EXCHANGE RATES, CO EXPECTS TOTAL EXPENSES OF CHF 50-60 MILLION\n* NO GUIDANCE CAN BE PROVIDED WITH REGARD TO NET CASH FLOW PROJECTIONS Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-08T14:16:00.000+02:00",
    "crawled": "2018-02-09T17:10:32.010+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "molecular",
        "partner",
        "ag",
        "financial",
        "performance",
        "expectation",
        "guidance",
        "molecular",
        "strong",
        "financial",
        "position",
        "chf",
        "million",
        "cash",
        "time",
        "deposit",
        "dec",
        "net",
        "cash",
        "used",
        "operating",
        "activity",
        "chf",
        "million",
        "operating",
        "loss",
        "chf",
        "million",
        "net",
        "loss",
        "chf",
        "million",
        "abicipar",
        "allergan",
        "track",
        "present",
        "phase",
        "efficacy",
        "data",
        "h2",
        "jörn",
        "aldag",
        "current",
        "chairman",
        "indicated",
        "wish",
        "stand",
        "agm",
        "full",
        "year",
        "constant",
        "exchange",
        "rate",
        "co",
        "expects",
        "total",
        "expense",
        "chf",
        "million",
        "guidance",
        "provided",
        "regard",
        "net",
        "cash",
        "flow",
        "projection",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}